Latest Darwin Global Management, Ltd. Stock Portfolio
$3.77Billion | No. of Holdings #6
About Darwin Global Management, Ltd. and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Darwin Global Management, Ltd. reported an equity portfolio of $3.8 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Darwin Global Management, Ltd. are INSM, BLTE, . The fund has invested 68.3% of it's portfolio in INSMED INC and 12.1% of portfolio in BELITE BIO INC. <br><br> The fund managers got completely rid off CIDARA THERAPEUTICS INC (CDTX), WAVE LIFE SCIENCES LTD (WVE) and CAPRICOR THERAPEUTICS INC (CAPR) stocks. They significantly reduced their stock positions in INSMED INC (INSM). Darwin Global Management, Ltd. opened new stock positions in REVOLUTION MEDICINES INC (RVMD), ROIVANT SCIENCES LTD (ROIV) and DIANTHUS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ABIVAX SA and BELITE BIO INC (BLTE).
Darwin Global Management, Ltd. Equity Portfolio Value
Last Reported on: 15 May, 2026
$3.77Billion
as of May 15, 2026Darwin Global Management, Ltd. Annual Return Estimates Vs S&P 500
- Performance
New Buys
| Ticker | $ Bought |
|---|---|
| revolution medicines inc | 204,983,000 |
| roivant sciences ltd | 179,517,000 |
| dianthus therapeutics inc | 1,456,600 |
New stocks bought by Darwin Global Management, Ltd.
Additions
| Ticker | % Inc. |
|---|---|
| abivax sa | 9.13 |
| belite bio inc | 0.98 |
Additions to existing portfolio by Darwin Global Management, Ltd.
Reductions
| Ticker | % Reduced |
|---|---|
| insmed inc | -19.72 |
Darwin Global Management, Ltd. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| wave life sciences ltd | -125,168,000 |
| cidara therapeutics inc | -220,181,000 |
| capricor therapeutics inc | -23,168,000 |
Darwin Global Management, Ltd. got rid off the above stocks
Sector Distribution
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 78.5 |
| Others | 21.5 |
Market Cap. Distribution
- LARGE-CAP
- UNALLOCATED
| Category | % |
|---|---|
| LARGE-CAP | 78.5 |
| UNALLOCATED | 21.5 |
Stocks belong to which Index?
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 73.8 |
| Others | 26.2 |
Darwin Global Management, Ltd. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Darwin Global Management, Ltd.
$3.77BTotal Value
9.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 BLTE Belite Bio IncBelite Bio IncBLTE | 12.1% | 3,057,410 | $456.11M 12.1% | 0.98%increased 0.98 percentadded | |
 Capricor Therapeutics Inc Darwin Global Management, Ltd.'s holding in Capricor Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Cidara Therapeutics Inc Darwin Global Management, Ltd.'s holding in Cidara Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Insmed Inc Insmed IncINSM Darwin Global Management, Ltd.'s holding in Insmed Inc over time | 68.33% | 16,805,200 | $2.58B 68.33% | 19.72%decreased 19.72 percentreduced | |
 Roivant Sciences Ltd Darwin Global Management, Ltd.'s holding in Roivant Sciences Ltd over time | 4.76% | 6,797,300 | $179.52M 4.76% | Newnew position | |
 Revolution Medicines Inc Darwin Global Management, Ltd.'s holding in Revolution Medicines Inc over time | 5.44% | 2,211,020 | $204.98M 5.44% | Newnew position | |
 Wave Life Sciences Ltd Darwin Global Management, Ltd.'s holding in Wave Life Sciences Ltd over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Sponsored Ads Abivax SaAbivax Sa | 9.34% | 3,468,660 | $352.07M 9.34% | 9.13%increased 9.13 percentadded | |
Com Dianthus Therapeutics IncDianthus Therapeutics Inc | 0.04% | 17,357 | $1.46M 0.04% | Newnew position | |